Interleukins-4, -5, and -13: Emerging therapeutic targets in allergic disease

Pharmacology and Therapeutics

Volumn 94, Issue 3, 2002, Pages 253-264

  Foster, Paul S ^a   Martinez Moczygemba, Margarita ^b   Huston, David P ^b   Corry, David B ^b  

^a Biology and Environment   (Australia)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Allergic disease; Asthma; Cytokine; Interleukin; Receptor; T helper type 2 cell

Indexed keywords

ALTRAKINCEPT; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; INTERLEUKIN 9; STAT PROTEIN; VACCINIA VACCINE; INTERLEUKIN RECEPTOR;

ALLERGIC ASTHMA; ALLERGIC DISEASE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CYTOKINE PRODUCTION; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH2 CELL; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

HUMAN; HYPERSENSITIVITY; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; RECEPTORS, INTERLEUKIN; TH2 CELLS; HUMANS;

EID: 0036020038     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(02)00220-6     Document Type: Review

References (100)

1. The mechanism of IL-5 signal transduction
2. Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-γ production in cells from allergic individuals and inhibit IgE synthesis in vitro
3. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial
4. Interleukin 4 is localized to and released by human mast cells
5. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines
6. Epitope-labeled soluble human interleukin-5 (IL-5) receptors. Affinity cross-link labeling, IL-5 binding, and biological activity
7. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice
8. Activated mast cells produce interleukin 13
9. IL-4 and IL-13 receptors: Are they one and the same?
10. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs
11. An update on interleukin-4 and its receptor
12. Regulation of human eosinophil precursor production by cytokines: A comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL-5, rhIL-6, and rh granulocyte-macrophage colony-stimulating factor
13. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice
14. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
15. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice
16. Requirement of CD4-positive T cells for cellular recruitment to the lungs of mice in response to a particulate intratracheal antigen
17. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family
18. Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5
19. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common β chain expression
20. The murine IL-13Rα2: Molecular cloning, characterization and comparison with murine IL-13Rα1
21. Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13
22. Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthma
23. CD40 signaling induces interleukin-4-independent IgE switching in vivo
24. IL-4 is required to generate and sustain in vivo IgE responses
25. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: Lessons from studies with rodent models
26. Eosinophils are the major effector cells of immunity to microfilariae in a mouse model of onchocerciasis
27. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
28. + T cells
29. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice
30. NIH conference. Asthma
31. High-affinity IgE receptor on eosinophils is involved in defence against parasites
32. An antagonistic IL-4 mutant prevents type I allergy in the mouse: Inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo
33. Requirement for IL-13 independently of IL-4 in experimental asthma
34. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): Reconstitution of a high-affinity GM-CSF receptor
35. Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma
36. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor
37. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity
38. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5
39. An interleukin-4-induced transcription factor: IL-4 Stat
40. Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor α promoter through activation and repression domains
41. Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation
42. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells
43. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice
44. Expression cloning of the human IL-3 receptor cDNA reveals a shared subunit for the human IL-3 and GM-CSF receptors
45. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma
46. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses
47. Regulatory effect of anti-interleukin-5 monoclonal antibody on intestinal worm burden in a primary infection with strongyloides venezuelensis in mice
48. Biological activity of IL-4 and IL-13 on human endothelial cells: Functional evidence that both cytokines act through the same receptor
49. The role of CpG motifs in innate immunity
50. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
51. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma
52. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis
53. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones
54. Impaired development of Th2 cells in IL-13-deficient mice
55. An interleukin 5 mutant distinguishes between two functional responses in human eosinophils
56. Oligonucleotide therapy of allergic asthma
57. Cloning of the human IL-13Rα1 chain and reconstitution with the IL4Rα of a functional IL-4/IL-13 receptor complex
58. Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor
59. Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse
60. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice
61. The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity
62. Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells
63. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: Similarities between IL-4 and IL-13 signaling
64. Structure of IL-13 receptor: Analysis of subunit composition in cancer and immune cells
65. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: Comparison between IL-4- and IL-13-induced signal transduction
66. Interleukin-13 receptor alpha′ but not alpha chain: A functional component of interleukin-4 receptors
67. The IL-4 receptor: Signaling mechanisms and biologic functions
68. Peptide nucleic acids: On the road to new gene therapeutic drugs
69. Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4
70. Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for interleukins 2, 4, 7, 9, and 15
71. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor
72. c chain of the IL-2 receptor
73. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow
74. c chain
75. 2
76. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells
77. Interleukin-9 and its receptor: Involvement in mast cell differentiation and T cell oncogenesis
78. Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues
79. Murine eotaxin: An eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression
80. Interleukin-5, eosinophils, and disease
81. The beta common chain (βc) of the granulocyte macrophage-colony stimulating factor, interleukin-3 and interleukin-5 receptors
82. Production of interleukin-4 and other cytokines following stimulation of mast cell lines and in vivo mast cells/basophils
83. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
84. Regulation of T-helper type 2 cell and airway eosinophilia by transmucosal coadministration of antigen and oligodeoxynucleotides containing CpG motifs
85. Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements
86. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides
87. Molecular cloning and expression of the murine interleukin-5 receptor
88. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF
89. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness
90. Antisense strategies: Functions and applications in immunology
91. Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types
92. Interferon γ-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major
93. Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in brown Norway rats
94. Adoptive transfer of allergic airway responses with sensitized lymphocytes in BN rats
95. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity
96. Immunologic basis of antigen-induced airway hyperresponsiveness
97. Interleukin-13: Central mediator of allergic asthma
98. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene
99. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3
100. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned IL-13 receptor and IL-4 receptor α-chains